May 8, 2026 08:12AM
May 7, 2026 08:01AM
Apr 13, 2026 08:31AM
Mar 19, 2026 05:58AM
Mar 6, 2026 06:09AM
Feb 27, 2026 08:59AM
Jan 30, 2026 08:31AM ALX Oncology prices $150 million stock and warrant offering
Jan 30, 2026 08:15AM
Nov 20, 2025 03:59AM
Nov 13, 2025 05:03AM
Nov 7, 2025 04:37PM
Aug 12, 2025 04:49PM
May 27, 2025 06:42AM
May 8, 2025 05:12PM ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c
Apr 25, 2025 01:10PM
Apr 25, 2025 09:01AM
Apr 7, 2025 08:01AM
Mar 7, 2025 09:01AM
Mar 6, 2025 05:19PM
Mar 6, 2025 02:14AM
Jan 27, 2025 10:36AM ALX Oncology (ALXO) PT Lowered to $2.20 at UBS
Jan 24, 2025 10:10AM
Jan 24, 2025 07:28AM
Jan 24, 2025 06:39AM
Jan 23, 2025 08:00AM
Dec 19, 2024 03:12AM
Dec 18, 2024 09:13AM
Dec 10, 2024 09:01AM ALX Oncology (ALXO) Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer
Nov 14, 2024 08:01AM
Nov 8, 2024 06:27AM
Aug 21, 2024 05:22AM
Aug 12, 2024 05:11AM
Aug 9, 2024 07:11AM
Aug 6, 2024 04:01PM
Jul 31, 2024 04:03PM ALX Oncology (ALXO) Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
Jul 31, 2024 06:51AM
Jun 10, 2024 08:47AM
Jun 10, 2024 06:53AM

396,721 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All